These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Mycobacterium ulcerans infection imported from Australia to Missouri, USA, 2012. Thomas BS; Bailey TC; Bhatnagar J; Ritter JM; Emery BD; Jassim OW; Hornstra IK; George SL Emerg Infect Dis; 2014 Nov; 20(11):1876-9. PubMed ID: 25341024 [TBL] [Abstract][Full Text] [Related]
24. Surgical management of buruli ulcer disease: a four-year experience from four endemic districts in ghana. Adu E; Ampadu E; Acheampong D Ghana Med J; 2011 Mar; 45(1):4-9. PubMed ID: 21572818 [TBL] [Abstract][Full Text] [Related]
26. Buruli ulcer (Mycobacterium ulcerans infection). Walsh DS; Portaels F; Meyers WM Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836 [TBL] [Abstract][Full Text] [Related]
27. Buruli ulcer disease in travelers and differentiation of Mycobacterium ulcerans strains from northern Australia. Lavender CJ; Globan M; Johnson PD; Charles PG; Jenkin GA; Ghosh N; Clark BM; Martinello M; Fyfe JA J Clin Microbiol; 2012 Nov; 50(11):3717-21. PubMed ID: 22875890 [TBL] [Abstract][Full Text] [Related]
28. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study. O'Brien DP; McDonald A; Callan P; Robson M; Friedman ND; Hughes A; Holten I; Walton A; Athan E PLoS Negl Trop Dis; 2012 Jan; 6(1):e1473. PubMed ID: 22272368 [TBL] [Abstract][Full Text] [Related]
29. Mycobacterium ulcerans infection. van der Werf TS; van der Graaf WT; Tappero JW; Asiedu K Lancet; 1999 Sep; 354(9183):1013-8. PubMed ID: 10501380 [TBL] [Abstract][Full Text] [Related]
30. Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya. Walsh DS; Eyase F; Onyango D; Odindo A; Otieno W; Waitumbi JN; Bulimo WD; Schnabel DC; Meyers WM; Portaels F Am J Trop Med Hyg; 2009 Dec; 81(6):1110-3. PubMed ID: 19996445 [TBL] [Abstract][Full Text] [Related]
31. Antibiotic complications during the treatment of Mycobacterium ulcerans disease in Australian patients. O'Brien DP; Friedman D; Hughes A; Walton A; Athan E Intern Med J; 2017 Sep; 47(9):1011-1019. PubMed ID: 28585259 [TBL] [Abstract][Full Text] [Related]
32. Risk factors for Mycobacterium ulcerans infection (Buruli Ulcer) in Togo ─ a case-control study in Zio and Yoto districts of the maritime region. Maman I; Tchacondo T; Kere AB; Piten E; Beissner M; Kobara Y; Kossi K; Badziklou K; Wiedemann FX; Amekuse K; Bretzel G; Karou DS BMC Infect Dis; 2018 Jan; 18(1):48. PubMed ID: 29351741 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Etuaful S; Carbonnelle B; Grosset J; Lucas S; Horsfield C; Phillips R; Evans M; Ofori-Adjei D; Klustse E; Owusu-Boateng J; Amedofu GK; Awuah P; Ampadu E; Amofah G; Asiedu K; Wansbrough-Jones M Antimicrob Agents Chemother; 2005 Aug; 49(8):3182-6. PubMed ID: 16048922 [TBL] [Abstract][Full Text] [Related]
35. Mycobacterium ulcerans disease in the middle belt of Ghana: An eight-year review from six endemic districts. Adu EJ; Ampadu E Int J Mycobacteriol; 2015 Jun; 4(2):138-42. PubMed ID: 26972882 [TBL] [Abstract][Full Text] [Related]
36. Global Epidemiology of Buruli Ulcer, 2010-2017, and Analysis of 2014 WHO Programmatic Targets. Omansen TF; Erbowor-Becksen A; Yotsu R; van der Werf TS; Tiendrebeogo A; Grout L; Asiedu K Emerg Infect Dis; 2019 Dec; 25(12):2183-2190. PubMed ID: 31742506 [TBL] [Abstract][Full Text] [Related]